Short-term, low-dose, non-steroidal anti-inflammatory drug application diminishes premature ovulation in natural-cycle IVF Satoshi Kawachiya, Tsunekazu Matsumoto, Daniel Bodri, Keiichi Kato, Yuji Takehara, Osamu Kato Reproductive BioMedicine Online Volume 24, Issue 3, Pages 308-313 (March 2012) DOI: 10.1016/j.rbmo.2011.12.002 Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Scheduling of oocyte retrieval in natural-cycle IVF with an imminent LH surge. GnRH=gonadotrophin-releasing hormone; OR=oocyte retrieval. Reproductive BioMedicine Online 2012 24, 308-313DOI: (10.1016/j.rbmo.2011.12.002) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions
Figure 2 Flow chart of patient events in natural-cycle IVF (nIVF) with and without non-steroidal anti-inflammatory drug (NSAID). OR=oocyte retrieval. Reproductive BioMedicine Online 2012 24, 308-313DOI: (10.1016/j.rbmo.2011.12.002) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions
Figure 3 Natural-cycle IVF outcome per scheduled cycle according to non-steroidal anti-inflammatory drug (NSAID) use. Sched=scheduled cycle; OR=oocyte retrieval; COC=cumulus–oocyte–complex; Insem=inseminated cycle; Fert=fertilized; ET=embryo transfer; CP=clinical pregnancy; LB=live birth. Reproductive BioMedicine Online 2012 24, 308-313DOI: (10.1016/j.rbmo.2011.12.002) Copyright © 2011 Reproductive Healthcare Ltd. Terms and Conditions